Inogen (INGN) Revenue Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Inogen | 165.85 Mn | 71.44 Mn | 37.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.00% |
| Dec 31, 2025 | 2.01% |
| Sep 30, 2025 | 4.45% |
| Jun 30, 2025 | 7.06% |
| Mar 31, 2025 | -0.21% |
| Dec 31, 2024 | 0.29% |
| Sep 30, 2024 | -0.65% |
| Jun 30, 2024 | -2.56% |
| Mar 31, 2024 | -2.86% |
| Dec 31, 2023 | -2.59% |
| Sep 30, 2023 | -2.50% |
| Jun 30, 2023 | -2.97% |
| Mar 31, 2023 | -1.81% |
| Dec 31, 2022 | 6.67% |
| Sep 30, 2022 | 8.83% |
| Jun 30, 2022 | 10.02% |
| Mar 31, 2022 | 8.89% |
| Dec 31, 2021 | 8.48% |
| Sep 30, 2021 | 8.27% |
| Jun 30, 2021 | 10.60% |
| Mar 31, 2021 | 12.39% |
| Dec 31, 2020 | 12.84% |
| Sep 30, 2020 | 12.76% |
| Jun 30, 2020 | 8.31% |
| Mar 31, 2020 | 19.76% |
| Dec 31, 2019 | 22.07% |
| Sep 30, 2019 | 25.57% |
| Jun 30, 2019 | 27.16% |
| Mar 31, 2019 | 30.72% |
| Dec 31, 2018 | 34.36% |
| Sep 30, 2018 | 36.96% |
| Jun 30, 2018 | 36.99% |
| Mar 31, 2018 | 38.08% |